Neuronox

Neuronox is a Botulinum toxin type A product developed by Medytox Inc., a South Korean biopharmaceutical company. Launched in 2006, it was Korea's first and the world's fourth Botulinum toxin type A product.
Neuronox has been registered in 31 countries, including Korea, Brazil, India, Hong Kong, Ukraine, Thailand, and Mexico, and is in the process of registration in an additional 30 countries.